Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy.

Altaf M., Nel C., Tipoe T., Edgar J., Zacharopoulou P., Srai D., Knight C., Lee M., Cherrill L-R., Falaschetti E., Ogbe A., Fletcher S., Box H., Elliott T., Kinloch S., Fox J., Clarke A., Pett S., Collins S., Balachandran M., Topping K., Terry L., Seaton K., Tomaras G., Uriel A., Orkin C., Ring K., Whitlock G., Boffito M., Sutherland R., Søgaard OS., Gunst JD., Brown H., Robinson N., Lindegard G., Goulder P., Taylor G., Caskey M., Nussenzweig M., Fidler S., Frater J., RIO Study Team .